Avant Diagnostics, Inc: 10-Q filed 2015-04-07

Name: Avant Diagnostics, Inc: 10-Q filed 2015-04-07
Creator: Avant Diagnostics, Inc
License: https://creativecommons.org/licenses/by/4.0/

What Avant Diagnostics, Inc reported in its quarterly report filed 2015-04-07 (fiscal Q1 2015): 15 published measures, 32 facts as tagged in accession 0001477932-15-002299.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-04-07
Fiscal period: fiscal Q1 2015
Accession: 0001477932-15-002299 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Avant Diagnostics, Inc filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-12-31	2,963,000	USD
At 2014-09-30	3,299,000	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-12-31	324,000	USD
At 2014-09-30	166,000	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-12-31	2,639,000	USD
At 2014-09-30	3,133,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-12-31	270,000	USD
At 2014-09-30	6,000	USD
At 2013-12-31	41,000	USD
At 2013-09-30	43,000	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-166,000	USD	92
2013-10-01 to 2013-12-31	-30,000	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-12-31	-6,638,000	USD
At 2014-09-30	-6,471,000	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	73,414,238	shares	92
2013-10-01 to 2013-12-31	45,053,000	shares	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-12-31	1,270,000	USD
At 2014-09-30	1,606,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	166,000	USD	92
2013-10-01 to 2013-12-31	30,000	USD	92

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	166,000	USD	92
2013-10-01 to 2013-12-31	30,000	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-12-31	80,409,000	shares
At 2014-09-30	71,655,800	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-12-31	10,197,000	USD
At 2014-09-30	9,932,000	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2014-12-31	-1,000,000	USD
At 2014-09-30	-400,000	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-166,000	USD	92
2013-10-01 to 2013-12-31	-30,000	USD	92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-766,000	USD	92
2013-10-01 to 2013-12-31	-30,000	USD	92

Inspect the source

Entity: Avant Diagnostics, Inc / CIK 0001451929
Captured: 2026-09-22 19:48 UTC
SEC response SHA-256: d177fe59e04e5f68863c1b563d8f09603b20a05b7c152ae5cd784ce4f3d161f7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001451929.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))